- All
- Company announcements
- Financial reports
ESPI Current Report, No. 2/2024, Conclusion of a framework agreement for the manufacture and supply of MYCODERN S.A. jelly products. (PLMDNPL00013)
January 23, 2024
The Management Board of Mycodern S.A. with its seat in Gdansk, Poland, “the Company”, informs that today it has entered into an agreement with an
ESPI Current Report, No. 1/2024, Publication of an announcement of an offer to subscribe for series E shares by shareholders with pre-emptive rights – change of subscription deadline for series E shares of MYCODERN S.A. (PLMDNPL00013)
January 23, 2024
22-01-2024 23:29:56 | Current | ESPI | 1/2024 The Management Board of Mycodern S.A., headquartered in Gdańsk _”the Company”_, in reference to ESPI Report No.
Current report EBI, No. 01/2024, Conclusion of an agreement with the auditing firm MYCODERN Spółka Akcyjna (PLMDNPL00013)
January 8, 2024
08-01-2024 13:04:11 | Current | EBI | 1/2024 The Management Board of Mycodern SA, with its seat in Gdańsk, Poland (the “Company”) announces that today
ESPI Current Report, No. 22/2023, Shareholder notifications regarding change in voting interest of MYCODERN S.A. (PLMDNPL00013)
December 30, 2023
30-12-2023 20:02:57 | Current | ESPI | 22/2023 The Management Board of Mycodern S.A. with its seat in Gdańsk _”the Company”_ informs that the Company
ESPI Current Report, No. 21/2023, Publication of an announcement of an offer to subscribe for series E shares by shareholders with subscription rights – update of the information document of MYCODERN S.A. (PLMDNPL00013)
December 28, 2023
28-12-2023 22:28:09 | Current | ESPI | 21/2023 The Board of Directors of Mycodern S.A. with its registered seat in Gdansk __quot;Issuer_quot; or _quot;Company_quot;_, with
ESPI Current Report, No. 20/2023, Publication of an announcement on the offer to subscribe for series E shares by shareholders with subscription rights – change of the subscription deadline for series E shares of MYCODERN S.A. (PLMDNPL00013)
November 29, 2023
29-11-2023 14:02:54 | Current | ESPI | 20/2023 The Management Board of Mycodern S.A. with its registered seat in Gdańsk _ the “Issuer” or the